Remote Tracking of Epilepsy Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01130649
Recruitment Status : Withdrawn (not funded)
First Posted : May 26, 2010
Last Update Posted : May 3, 2017
San Francisco Veterans Affairs Medical Center
Information provided by (Responsible Party):
John Hixson, University of California, San Francisco

May 24, 2010
May 26, 2010
May 3, 2017
July 2010
July 2011   (Final data collection date for primary outcome measure)
  • Seizure frequency per month [ Time Frame: 1 year ]
    Assessment of seizure count accuracy by assessing total number of seizures reported per month
  • Medication compliance [ Time Frame: 1 year ]
    Assessment of compliance with taking medications at regularly scheduled intervals
  • Quality of life [ Time Frame: 1 year ]
    Quality of Life in Epilepsy inventory, to assess for overall change in quality of life measures
Same as current
Complete list of historical versions of study NCT01130649 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Remote Tracking of Epilepsy Patients
Pilot Study of Real-time Automated Tracking System for Patients With Epilepsy
The investigators propose a novel method for tracking the seizure frequency, side effect burden, and medication compliance for patients with epilepsy. The investigators intend to utilize a table-top device currently for tracking other chronic disease to collect remote data from epilepsy patients. The hypothesis is that the use of this device will lead to better longterm treatment outcomes than the standard outpatient mechanism of following patients longitudinally.
Not Provided
Observational Model: Other
Time Perspective: Other
Not Provided
Not Provided
Probability Sample
Patients will be recruited from the UCSF and VAMC Outpatient Epilepsy Centers. All study participants must have a confirmed diagnosis of epilepsy (defined by two or more unprovoked seizures) for at least 6 months.
Device: HealthBuddy
Noninvasive device for remotely reporting health information. The device does nothing to change the health of the patient, but transmits health data that is entered by the patient directly to the physician's office. Patients will enter data on seizure frequency, medication compliance, and side effects.
Other Name: Healthbuddy is a product of Bosch Healthcare, and is already utilized in many medical institutions around the country, including the VA Health System.
  • Epilepsy patients, electronic diary
    Cohort of epilepsy patient using an electronic diary system to record all seizures, side effects, and medication compliance
    Intervention: Device: HealthBuddy
  • Epilpesy patient, no electronic diary
    Group of epilepsy patients who are followed using the standard of care, which is a paper diary and routine outpatient follow up visits
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
July 2013
July 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Eligible participants must have a definitive diagnosis of epilepsy for at least 6 months, based on the clinical judgement of the investigators. Epilepsy is defined by two or more unprovoked seizures. Clinical history, electroencephalography, and imaging data are all instrumental in rendering a formal decision. The seizure type, frequency, or severity are not criteria for exclusion, although this information will be recorded.

Patient can range in age from birth to 65 years old; in cases of child participants, the parents are responsible for data reporting.

  • Patients must have a seizure frequency of at least two seizures in a 6 month period of time.
  • Patients must be on at least one anti-epileptic medication.
  • Patients and/or legal guardian must be able to report seizure frequency with either a paper or electronic diary.
  • Patients and/or legal guardians must be able to read and understand either English or Spanish.
  • Patients and/or legal guardians must be able to complete questionnaires and provide informed consent to this study.

Exclusion Criteria:

  • Exclusion criteria include: a diagnosis of psychogenic nonepileptic seizures; severe depression, anxiety, or psychosis
  • Recent problem with substance abuse.
Sexes Eligible for Study: All
6 Months to 65 Years   (Child, Adult, Older Adult)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
John Hixson, University of California, San Francisco
University of California, San Francisco
San Francisco Veterans Affairs Medical Center
Principal Investigator: John Hixson, MD University of California, San Francisco
University of California, San Francisco
May 2017